Leadership Overview
Rho has 6 executives leading key functions including strategy, operations, finance, technology, medical oversight, and corporate leadership.
Committed to advancing global health outcomes, Rho delivers comprehensive clinical research services that accelerate the drug development process for pharmaceutical and biotechnology partners worldwide.
Committed to advancing global health outcomes, Rho delivers comprehensive clinical research services that accelerate the drug development process for pharmaceutical and biotechnology partners worldwide.
Leadership Roles at Rho
Lawrence Morentz - Chief Executive Officer
Lawrence Morentz, the Chief Executive Officer at Rho, directs the overarching strategic vision and long-term growth trajectory of the organization. By aligning clinical research capabilities with evolving pharmaceutical industry demands, the Chief Executive Officer ensures the company maintains a competitive edge in drug development services. Lawrence Morentz oversees high-level interactions with the Board and key stakeholders to secure sustainable expansion across North American and international markets. This leadership role involves fostering a culture of scientific excellence and operational integrity. Through the implementation of rigorous quality standards, the Chief Executive Officer drives the delivery of complex clinical trials. By prioritizing innovation in research methodologies, the Chief Executive Officer strengthens the market position of the firm. Ultimately, the Chief Executive Officer secures the financial and operational health of the enterprise while guiding the organization toward future milestones in the global life sciences sector.
Michael Szarowicz - Chief Financial Officer
Michael Szarowicz, the Chief Financial Officer at Rho, governs the fiscal strategy and financial planning activities of the organization. By overseeing capital allocation and budgeting processes, the Chief Financial Officer ensures the company maintains the necessary resources to support large-scale clinical research initiatives. Michael Szarowicz manages financial reporting and risk assessment to provide transparency for the Board and external partners. This leadership role involves analyzing market trends to inform investment decisions in new research technologies and infrastructure. By optimizing the cost structure of clinical operations, the Chief Financial Officer improves overall profitability and long-term stability. The Chief Financial Officer works closely with the executive team to align financial goals with the broader mission of accelerating drug development. Through disciplined fiscal management, the Chief Financial Officer supports the expansion of service offerings. Ultimately, the Chief Financial Officer secures the financial foundation required for the continued success of the firm.
Alena Hammond - Chief Operating Officer
Alena Hammond, the Chief Operating Officer at Rho, manages the daily execution of clinical research projects and internal business processes. By optimizing resource allocation across diverse therapeutic areas, the Chief Operating Officer ensures that project timelines meet stringent regulatory requirements. Alena Hammond coordinates cross-functional teams to streamline the drug development lifecycle, enhancing efficiency for global clients. This leadership role involves monitoring operational performance metrics to identify areas for continuous improvement. By integrating advanced project management tools, the Chief Operating Officer maintains high standards of data accuracy and trial integrity. The Chief Operating Officer collaborates with other executive leaders to align operational capacity with business development goals. Through the management of complex logistics and site coordination, the Chief Operating Officer supports the successful completion of clinical trials. Ultimately, the Chief Operating Officer drives operational excellence to sustain the reputation of the firm as a premier research partner.
Deborah Johnson - President
Deborah Johnson, the President at Rho, leads the organizational culture and oversees the execution of corporate initiatives across all business units. By fostering collaboration between departments, the President ensures that the company maintains a unified approach to delivering high-quality clinical research services. Deborah Johnson drives the implementation of corporate policies that support employee development and operational efficiency. This leadership role involves representing the firm in industry forums and building relationships with key pharmaceutical partners. By monitoring the competitive landscape, the President identifies opportunities for market expansion and service diversification. The President works in tandem with the executive team to translate the long-term vision into actionable business plans. Through the management of internal communications and organizational change, the President maintains alignment with the core mission of the firm. Ultimately, the President secures the operational success and market reputation of the organization through dedicated leadership and strategic oversight.
Biljana Djordjevic - Technology Chief of Staff
Biljana Djordjevic, the Technology Chief of Staff at Rho, architects the digital infrastructure and technological strategy supporting clinical research operations. By implementing secure data management systems, the Technology Chief of Staff ensures compliance with global regulatory standards for electronic records. Biljana Djordjevic coordinates the integration of advanced analytics and software solutions to enhance the efficiency of the drug development process. This leadership role involves bridging the gap between technical teams and operational departments to ensure seamless technology adoption. By overseeing the deployment of innovative digital tools, the Technology Chief of Staff drives improvements in trial data collection and analysis. The Technology Chief of Staff collaborates with the executive team to align technical capabilities with the strategic objectives of the firm. Through the management of cybersecurity protocols and system scalability, the Technology Chief of Staff protects sensitive research data. Ultimately, the Technology Chief of Staff enables the organization to leverage technology for superior clinical outcomes.
Andrew Feigin - Chief Medical Officer
Andrew Feigin, the Chief Medical Officer at Rho, provides clinical leadership and scientific oversight for all drug development programs. By guiding the design and execution of complex clinical trials, the Chief Medical Officer ensures that research protocols meet the highest medical and ethical standards. Andrew Feigin advises internal teams and external clients on regulatory pathways and safety monitoring throughout the development lifecycle. This leadership role involves interpreting clinical data to inform strategic decisions regarding trial progression and therapeutic efficacy. By maintaining deep expertise in medical science, the Chief Medical Officer enhances the credibility of the research services provided by the firm. The Chief Medical Officer collaborates with the executive team to ensure that medical strategy aligns with the overall business mission. Through the oversight of medical writing and safety reporting, the Chief Medical Officer supports the successful delivery of clinical results. Ultimately, the Chief Medical Officer drives scientific rigor to advance patient health.
Explore Leadership Teams in Business Services
ANSER was founded in 1958 as a public service research institute organized as a not-for-profit corporation dedicated to informing decisions that shape the nation's future. The company provides program management and objective studies and analyses to the national security, homeland security, and public policy communities. ANSER also builds and leads technology development collaborations through its subsidiary, Advanced Technology International (ATI), specializing in organizing and managing research and development consortia on behalf of the federal government.
Company Leadership CS


SH
Aragen Life Sciences is a company that specializes in research and development operations for pharma, biotech, agrochemical, and animal health companies among other industries. They are based in Hyderabad, India.
Company Leadership MK

PN
Addverb provides smart end-to-end warehouse and industrial automation and intralogistics solutions. Addverb's fleet of automated robots, material handling technologies, and software solutions comprising an extensive portfolio of fixed and flexible automation solutions help improve the performance and accuracy of warehouse and factory operations. Addverb's mission is to discover a customer's warehousing problem, design an appropriate customized automation solution to the identified problem, deliver the solution, and provide dedicated after-sales support. Addverb's headquarters, manufacturing, and R&D facilities are in India, with global offices in Australia, Singapore, the Netherlands, the USA, Germany, and the UAE.
Company Leadership AK
NK
SN
PJ
The American Institutes for Research (AIR) is one of the leading behavioral and social science research organizations in the world. Our overriding goal is to use the best science available to bring the most effective ideas and approaches to enhancing everyday life. For us, making the world a better place is not wishful thinking. It is the goal that drives us.Founded in 1946 as a not-for-profit organization, AIR is a carefully designed institution motivated by the desire to enhance the human experience. We are committed to contributing to the science of human behavior and the development of mans capacities and potential.Our work spans a wide range of substantive areas: education, student assessment, international education, individual and organizational performance, health research and communication, human development, usability design and testing, talent management, employment equity, and statistical and research methods. The intellectual diversity of our more than 1,800 employees, more than 50 percent of whom hold advanced degrees, enables us to bring together experts in many fields, including education, psychology, sociology, economics, psychometrics, statistics, public health, usability engineering, software design, graphics and video communicationsall in the search for innovative answers to any challenge.We conduct our work within a culture and philosophy of strict independence, objectivity, and non-partisanship, as we tackle societys most important issues.
Company Leadership BK

LS
PK